STOCK TITAN

Tactile Medical to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 20, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Tactile Medical, a medical technology company, will release its fourth quarter and fiscal year 2023 financial results on February 20th. The company will host a conference call to discuss the results, and a live webcast will be available on the investor relations section of the Company's website. Those interested in participating can dial in or access the webcast. A replay will also be available for two weeks.
Positive
  • None.
Negative
  • None.

MINNEAPOLIS, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2023 financial results will be released before the market opens on Tuesday, February 20th.

Management will host a conference call with a question and answer session at 8:00 a.m. Eastern Time on February 20th to discuss the results of the quarter and fiscal year. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13744163. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.

For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13744163. The webcast will be archived at investors.tactilemedical.com.

About Tactile Systems Technology, Inc. (DBA Tactile Medical)

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. The company collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.


The financial results will be released before the market opens on Tuesday, February 20th.

You can participate by dialing 877-407-3088 (201-389-0927 for international callers) and providing access code 13744163.

The live webcast will be provided on the investor relations section of the Company's website at investors.tactilemedical.com.

The replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers) with access code 13744163.

The ticker symbol for Tactile Medical is 'TCMD'.
Tactile Systems Technology Inc

NASDAQ:TCMD

TCMD Rankings

TCMD Latest News

TCMD Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
US
Minneapolis

About TCMD

tactile medical is one of the fastest growing companies in medical devices. as a leader in treatment options for lymphedema and venous ulcer therapies, tactile medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling . headquartered in minneapolis, minnesota, we advocate for patient access and serve tens of thousands of patients through a direct national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff.